Calderon Chacon, JaninneGaray Borcosque, Andres M.Lijeron Viana de Araujo, Luccas2025-05-192024https://repositorio.ucb.edu.bo/handle/20.500.12771/1176Background: Long-acting antiretroviral therapies (ARV-LA) have emerged as an alternative to daily oral regimens for the management of HIV. This systematic review evaluates the efficacy, safety, and patient satisfaction of ARV-LA, particularly focusing on cabotegravir (CAB-LA) and rilpivirine (RPV-LA), in comparison to standard oral antiretroviral therapies (ART).enHIVLong-Acting Antiretroviral TherapyCabotegravirRilpivirineViral SuppressionSafetyArticle